A Prospective Observational study to describe the pattern and effectiveness of the utilization of different treatment options for Metastatic Renal Cell Carcinoma (OPERA)

Description :

This is a regional, multicenter observational prospective study, to obtain routine clinical practice data on the usage patterns and outcomes (safety and effectiveness) of immunotherapy and/or TKI, for metastatic renal cell carcinoma in real-life practice. One hundred eighty-five patients diagnosed with metastatic renal cell carcinoma and will start on immunotherapy and/or TKI in this observational study. Data on efficacy and safety will be recorded at different time-points: at baseline, during treatment at 4 weeks, 3, 6, 12 and 36 months, and at every follow-up once yearly after the last administration of immunotherapy and TKI until last follow-up, patient death, or data collection cut off point.